Rivaroxaban

Also sold as Xarelto, XARELTO, Rivaroxaban, RIVAROXABAN

Medicine summary · from official FDA labels · Oct 19, 2026

Serious warning: WARNING: (A) PREMATURE DISCONTINUATION OF XARELTO INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA A. Premature discontinuation of XARELTO increases the risk of thrombotic events Premature discontinuation of any oral anticoagulant, including XARELTO, increases the risk of thrombotic events.

What it’s used for

Rivaroxaban tablet is a factor Xa inhibitor indicated: to reduce the risk of major cardiovascular events in patients with coronary artery disease (CAD) (1. 7) to reduce the risk of major thrombotic vascular events in patients with peripheral artery disease (PAD), including patients after recent lower extremity revascularization due to symptomatic PAD (1.

How to take it

2 DOSAGE AND ADMINISTRATION CAD or PAD: 2. 5 mg orally twice daily with or without food, in combination with aspirin (75 to 100 mg) once daily ( 2.

Important warnings

Risk of bleeding: Rivaroxaban can cause serious and fatal bleeding. ( 5.

Common side effects

The following clinically significant adverse reactions are also discussed in other sections of the labeling: Increased Risk of Stroke After Discontinuation in Nonvalvular Atrial Fibrillation [see Boxed Warning and Warnings and Precautions ( 5. 1 )] Bleeding Risk [see Warnings and Precautions ( 5.

Interactions

Avoid combined P-gp and strong CYP3A inhibitors and inducers ( 7.

If pregnant or breastfeeding

Forms & strengths

10 MG Oral Tablet · 15 MG Oral Tablet · 20 MG Oral Tablet · 2.5 MG Oral Tablet · 1 MG/ML Oral Suspension

Questions to ask your doctor or pharmacist

Is this the right medicine for my condition, and how long should I take it?
What side effects should I watch for, and which need urgent attention?
Does this interact with my other medicines, supplements, or alcohol?
What should I do if I miss a dose or take too much?